New NASs reviewed by medicine prices review board Canada 2014-2021 by improvement
The Patented Medicine Prices Review Board reviewed classified no NAS as a substantial improvement in 2021. This statistic depicts the new active substances (NASs) reviewed by the Patented Medicine Prices Review Board in Canada from 2014 to 2021, by therapeutic improvement.